Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open-label, Long-term Extension Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients

NCT03780543 is registered in ClinicalTrials.gov with Assembly Biosciences as lead sponsor.

NCT NCT03780543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03780543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open-label, Long-term Extension Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients
Lead sponsor
Assembly Biosciences
Phase
Phase 2
Overall status
Terminated
Start date
December 20, 2018
Completion date
April 26, 2021
Enrollment
92 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b